Accomplished chief executive officer formerly with Epocrates and Carefx
EMERYVILLE, Calif., May 15, 2013 – MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Andrew Hurd has been named the company’s chief executive officer. Hurd will spearhead the company’s continued growth, promoting MedeAnalytics’ solutions in the burgeoning healthcare data analytics market. Mike Gallagher, former chief executive officer, will continue to serve as MedeAnalytics’ executive chairman.
Hurd brings more than 25 years of healthcare IT experience and leadership to MedeAnalytics, including product and market innovation and a track record of building strong strategic partnerships. He was previously CEO of Epocrates (NASDAQ: EPOC), the market leading mobile platform for clinical content and practice tools at the point of care, which was recently purchased by athenahealth (NASDAQ: ATHN). Prior to Epocrates, Hurd served as chairman and CEO of Carefx, which was acquired by Harris Corporation (NYSE: HRS) in 2011. Before Carefx, Hurd held senior management positions at WebMD, LLC (NASDAQ: WBMD) and QuadraMed Corporation. He serves on the board of directors for ABILITY Network Inc.
“I have admired MedeAnalytics and what the company has accomplished for some time,” said Hurd. “I am incredibly excited about leading the company and the promising opportunities that lie ahead.”
“We are pleased to have Andy join our company,” said Gallagher. “We look forward to Andy’s leadership in advancing the vision of MedeAnalytics in serving the healthcare provider, payer and UK markets.”
Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.